Recursion Pharma Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Name: Recursion Pharmaceuticals Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
Rating: 0.910319375
Author: Trendlyne DVM scores

Weak Stock

about

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improvi...

3.38 0.09 (2.74%)

52.92% Fall from 52W High

10.8M

XNAS Volume

XNAS 13 Mar, 2026 2:16 PM (EDT)

Board Meeting

The next board meeting for Recursion Pharma Inc (Class A) is on 17 Mar 2026 for the purpose of KeyBanc 2026 Healthcare Forum See details

Low Financial Strength

11.1 / 100

Expensive Valuation

16.3 / 100

Technically Bearish

34.3 / 100

Weak Stock These stocks have poor scores across the board. Investors should be very cautious with these stocks View Similar Embed DVM

1Yr Price target upside is 99%

7 analysts

Recursion Pharma Inc (Class A) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Recursion Pharma Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improvi...

52.92% Fall from 52W High

SWOT Analysis

Recursion Pharma Inc (Class A) Live Price Chart